Cervical cancer Immunotherapy has gained popularity in various solid tumors. Pembro and nivo works in patients with recurrent or advanced cervical cancer. But new targeted therapies have to identified. BRCA, PIK3CA, DDR, and NTRK are potential targets Reply Your name Subject Commentaire About text formats Langue AnglaisSpanishFrenchItalianAllemand The comment language code. Save
Cervical cancer Immunotherapy has gained popularity in various solid tumors. Pembro and nivo works in patients with recurrent or advanced cervical cancer. But new targeted therapies have to identified. BRCA, PIK3CA, DDR, and NTRK are potential targets Reply
Cervical cancer
Immunotherapy has gained popularity in various solid tumors. Pembro and nivo works in patients with recurrent or advanced cervical cancer. But new targeted therapies have to identified. BRCA, PIK3CA, DDR, and NTRK are potential targets